Ignite Creation Date:
2025-12-25 @ 2:16 AM
Ignite Modification Date:
2026-01-25 @ 4:40 AM
Study NCT ID:
NCT00004260
Status:
COMPLETED
Last Update Posted:
2011-08-03
First Post:
2000-01-28
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Interleukin-12 Plus Rituximab in Treating Patients With Non-Hodgkin's Lymphoma
Sponsor:
Mayo Clinic
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
CDR0000067514
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Stephen Maxted Ansell, M.D.
Old Organization:
Mayo Clinic Cancer Center
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | NIH | View |